Beasley, G., Farrow, N., Landa, K., Seilm, M. A., Jung, S.-H., Bigner, D., … Salama, A. (2020). 302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma. In Regular and young investigator award abstracts (p. A185.1-A185). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2020-sitc2020.0302

Beasley, Georgia, Nellie Farrow, Karenia Landa, Maria Angelica Seilm, Sin-Ho Jung, Darell Bigner, Andrea True Kelly, Smita Nair, Matthias Gromeier, and April Salama. “302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma.” In Regular and Young Investigator Award Abstracts, A185.1-A185. BMJ Publishing Group Ltd, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0302.

Beasley G, Farrow N, Landa K, Seilm MA, Jung S-H, Bigner D, et al. 302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma. In: Regular and young investigator award abstracts. BMJ Publishing Group Ltd; 2020. p. A185.1-A185.

Beasley, Georgia, et al. “302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2020, p. A185.1-A185. Crossref, doi:10.1136/jitc-2020-sitc2020.0302.

Beasley G, Farrow N, Landa K, Seilm MA, Jung S-H, Bigner D, Kelly AT, Nair S, Gromeier M, Salama A. 302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma. Regular and young investigator award abstracts. BMJ Publishing Group Ltd; 2020. p. A185.1-A185.